Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)

Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2021-2025)

The global osteoarthritis market revenues are forecasted to touch US$10.92 billion in 2025, growing at a CAGR of 9.85% for the period spanning from 2021 to 2025.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

In 2020, the outbreak of COVID-19 pandemic has created an unfavorable impact on the market as the osteoarthritis therapeutics sales declined during Q1-2020.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels

Scope of the report:

The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
The competitive landscape of the market, along with the company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Target Audience:

Osteoarthritis Therapeutics Manufacturers
Ingredient Suppliers
End Users
Consulting Firms
Investment Banks
Government Bodies & Regulating Authorities


1. Market Overview
1.1 Introduction
1.2 Causes
1.3 Symptoms
1.4 Diagnosis
1.5 Treatment
2. Global Osteoarthritis Market Analysis
2.1 Global Osteoarthritis Market Value
Table 1: Global Osteoarthritis Market Value (2016-2020)
2.2 Global Osteoarthritis Market Value Forecast
Table 2: Global Osteoarthritis Market Value Forecast (2021-2025)
2.3 Global Osteoarthritis Market Value by Anatomy Type
Table 3: Global Osteoarthritis Market Value by Anatomy Type (2020)
2.3.1 Global Knee Osteoarthritis Market Value
Table 4: Global Knee Osteoarthritis Market Value (2016-2020)
2.3.2 Global Knee Osteoarthritis Market Value Forecast
Table 5: Global Knee Osteoarthritis Market Value Forecast (2021-2025)
2.3.3 Global Knee Osteoarthritis Market Value by Region
Table 6: Global Knee Osteoarthritis Market Value by Region (2020)
2.4 Global Osteoarthritis Market Value by Treatment Type
Table 7: Global Osteoarthritis Market Value by Treatment Type (2020)
2.4.1 Global Osteoarthritis IA Injections Market Value
Table 8: Global Osteoarthritis IA Injections Market Value (2016-2020)
2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
Table 9: Global Osteoarthritis IA Injections Market Value Forecast (2021-2025)
2.4.3 Global Osteoarthritis Drugs Market Value
Table 10: Global Osteoarthritis Drugs Market Value (2016-2020)
2.4.4 Global Osteoarthritis Drugs Market Value Forecast
Table 11: Global Osteoarthritis Drugs Market Value Forecast (2021-2025)
2.4.5 Global Osteoarthritis Drugs Market Value by Type
Table 12: Global Osteoarthritis Drugs Market Value by Type (2020)
2.4.6 Global Osteoarthritis NSAIDs Market Value
Table 13: Global Osteoarthritis NSAIDs Market Value (2016-2020)
2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
Table 14: Global Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
2.4.8 Global Osteoarthritis Analgesics Market Value
Table 15: Global Osteoarthritis Analgesics Market Value (2016-2020)
2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
Table 16: Global Osteoarthritis Analgesics Market Value Forecast (2021-2025)
2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
Table 17: Global Osteoarthritis Drugs Market Value by Route of Administration (2020)
2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
Table 18: Global Osteoarthritis Parenteral Drugs Market Value (2016-2020)
2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
Table 19: Global Osteoarthritis Parenteral Drugs Market Value Forecast (2021-2025)
2.4.13 Global Osteoarthritis Oral Drugs Market Value
Table 20: Global Osteoarthritis Oral Drugs Market Value (2016-2020)
2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
Table 21: Global Osteoarthritis Oral Drugs Market Value Forecast (2021-2025)
2.5 Global Osteoarthritis Market Value by Distribution Channels
Table 22: Global Osteoarthritis Market Value by Distribution Channels (2020)
2.6 Global Osteoarthritis Market Value by Region
Table 23: Global Osteoarthritis Market Value by Region (2020)
3. Regional Osteoarthritis Market Analysis
3.1 North America
3.1.1 North America Osteoarthritis Market Value
Table 24: North America Osteoarthritis Market Value (2016-2020)
3.1.2 North America Osteoarthritis Market Value Forecast
Table 25: North America Osteoarthritis Market Value Forecast (2021-2025)
3.1.3 North America Osteoarthritis Market Value by Anatomy Type
Table 26: North America Osteoarthritis Market Value by Anatomy Type (2020)
3.1.4 North America Knee Osteoarthritis Market Value
Table 27: North America Knee Osteoarthritis Market Value (2016-2020)
3.1.5 North America Knee Osteoarthritis Market Value Forecast
Table 28: North America Osteoarthritis Market Value Forecast (2021-2025)
3.1.6 North America Osteoarthritis Market Value by Country
Table 29: North America Osteoarthritis Market Value by Country (2020)
3.1.7 The U.S. Osteoarthritis Market Value
Table 30: The U.S. Osteoarthritis Market Value (2016-2020)
3.1.8 The U.S. Osteoarthritis Market Value Forecast
Table 31: The U.S. Osteoarthritis Market Value Forecast (2021-2025)
3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
Table 32: The U.S. Osteoarthritis Market Value by Treatment Type (2020)
3.1.10 The U.S. Osteoarthritis IA Injections Market Value
Table 33: The U.S. Osteoarthritis IA Injections Market Value (2016-2020)
3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
Table 34: The U.S. Osteoarthritis IA Injections Market Value Forecast (2021-2025)
3.1.12 The U.S. Osteoarthritis Drugs Market Value
Table 35: The U.S. Osteoarthritis Drugs Market Value (2016-2020)
3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
Table 36: The U.S. Osteoarthritis Drugs Market Value Forecast (2021-2025)
3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
Table 37: The U.S. Osteoarthritis Drugs Market Value by Type (2020)
3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
Table 38: The U.S. Osteoarthritis NSAIDs Market Value (2016-2020)
3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
Table 39: The U.S. Osteoarthritis NSAIDs Market Value Forecast (2021-2025)
3.1.17 The U.S. Osteoarthritis Analgesics Market Value
Table 40: The U.S. Osteoarthritis Analgesics Market Value (2016-2020)
3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
Table 41: The U.S. Osteoarthritis Analgesics Market Value Forecast (2021-2025)
3.2 Europe
3.2.1 Europe Osteoarthritis Market Value
Table 42: Europe Osteoarthritis Market Value (2016-2020)
3.2.2 Europe Osteoarthritis Market Value Forecast
Table 43: Europe Osteoarthritis Market Value Forecast (2021-2025)
3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
Table 44: Europe Osteoarthritis Market Value by Anatomy Type (2020)
3.2.4 Europe Knee Osteoarthritis Market Value
Table 45: Europe Knee Osteoarthritis Market Value (2016-2020)
3.2.5 Europe Knee Osteoarthritis Market Value Forecast
Table 46: Europe Knee Osteoarthritis Market Value Forecast (2021-2025)
3.3 Asia-Pacific
3.3.1 Asia-Pacific Osteoarthritis Market Value
Table 47: Asia-Pacific Osteoarthritis Market Value (2016-2020)
3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
Table 48: Asia-Pacific Osteoarthritis Market Value Forecast (2021-2025)
3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
Table 49: Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2020)
3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
Table 50: Asia-Pacific Knee Osteoarthritis Market Value (2016-2020)
3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast
Table 51: Asia-Pacific Knee Osteoarthritis Market Value Forecast (2021-2025)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Inclining Occurrence of Osteoarthritis
Table 52: Global Osteoarthritis Population (2016-2020)
4.1.2 Growing Geriatric Population
Table 53: Global Geriatric Population (2016-2020)
4.1.3 Rising Healthcare Expenditure per Capita
Table 54: Global Healthcare Expenditure per Capita (2016-2020)
4.1.4 Growing Obese Population
Table 55: The U.S. Obese Population (2016-2020)
4.1.5 Improving Consumer Confidence Index
Table 56: Consumer Confidence Index in US and Europe (2016-2020)
4.2 Key Trends and Developments
4.2.1 Growth in Pharmaceutical R&D Expenditures
Table 57: Global Pharmaceutical R&D Expenditures (2016-2020)
4.2.2 Progressing Product Pipeline
4.2.3 Advancement in Osteoarthritis Treatments
4.2.4 Growth in Online Pharmaceutical Sales
Table 58: Global Online Pharmaceutical Sales (2020-2025)
4.3 Challenges
4.3.1 Associated Business Risk
4.3.2 Patient Health-Associated Risk
4.3.3 Stringent Regulations
5. Competitive Landscape
5.1 Global Osteoarthritis Market
5.1.1 Key Players – Revenues Comparison
Table 59: Key Players – Revenues Comparison (2020)
5.1.2 Key Players – Market Cap Comparison
Table 60: Key Players – Market Cap Comparison
5.1.3 Key Players – R&D Expenditures Comparison
Table 61: Key Players – R&D Expenditures Comparison (2019/2020)
6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
6.1.2 Financial Overview
Table 62: J&J Sales and Earnings (2016-2020)
Table 63: J&J Sales by Segments (2020)
6.1.3 Business Strategies
6.2 Novartis AG
6.2.1 Business Overview
6.2.2 Financial Overview
Table 64: Novartis Net Sales and Net Income (2016-2020)
Table 65: Novartis Net Sales by Segments (2020)
6.2.3 Business Strategies
6.3 Bayer AG
6.3.1 Business Overview
6.3.2 Financial Overview
Table 66: Bayer Net Sales and Net Income (Loss) (2016-2020)
Table 67: Bayer Net Sales by Segments (2020)
6.3.3 Business Strategies
6.4 GlaxoSmithKline Plc
6.4.1 Business Overview
6.4.2 Financial Overview
Table 68: GSK Turnover and Profit (2016-2020)
Table 69: GSK Turnover by Segment (2020)
Table 70: GSK Turnover by Region (2020)
6.4.3 Business Strategies
6.5 Pfizer Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
Table 71: Pfizer Revenues and Net Income (2016-2020)
Table 72: Pfizer Revenues by Region (2020)
6.5.3 Business Strategies
6.6 Sanofi S.A.
6.6.1 Business Overview
6.6.2 Financial Overview
Table 73: Sanofi Net Sales and Net Income (2016-2020)
Table 74: Sanofi Net Sales by Segments (2020)
Table 75: Sanofi Net Sales by Region (2020)
6.6.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook